Today: 31 January 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus

CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus

NEW YORK, Jan 15, 2026, 12:50 EST — Regular session CrowdStrike Holdings Inc (CRWD.O) shares rose on Thursday after a U.S. judge dismissed a shareholder fraud lawsuit tied to the company’s July 2024 software outage. The stock was up 1.2% at $466.07 in midday trading, after closing at $460.70 in the prior session. (Investing.com) The ruling trims a legal overhang…
15 January 2026
·····
Shopify stock ticks higher after Toronto tech rout as AI-shopping push stays in view

Shopify stock ticks higher after Toronto tech rout as AI-shopping push stays in view

New York, Jan 15, 2026, 12:45 PM ET — Regular session Shares of Shopify Inc climbed roughly 0.8% to $158.7 on Thursday, bucking a volatile market following a selloff in Canadian tech stocks the day before. This matters because Shopify now acts as a high-beta barometer for risk appetite in software and online retail. When investors pull back from growth…
15 January 2026
·····
Capital One stock rises as traders weigh US credit-card rate cap risk ahead of earnings

Capital One stock rises as traders weigh US credit-card rate cap risk ahead of earnings

New York, Jan 15, 2026, 12:31 PM ET — Trading in the regular session. Shares of Capital One Financial Corp climbed Thursday, building on a recovery after earlier declines as investors reconsidered the policy risks tied to U.S. credit-card pricing. The stock gained 2.2%, reaching $239.55 by midday trading. The lender is at the heart of the debate about whether…
15 January 2026
····
Adobe stock slips again as Oppenheimer downgrade and Apple’s Creator Studio keep pressure on ADBE

Adobe stock slips again as Oppenheimer downgrade and Apple’s Creator Studio keep pressure on ADBE

New York, January 15, 2026, 12:42 EST — Regular session Adobe Inc shares edged down 0.6% to $302.49 on Thursday midday, even as the Invesco QQQ Trust tracking the Nasdaq 100 rose about 1%. Salesforce slid more than 3%, while the S&P 500 ETF SPY added about 0.6%. The slide comes two days after Oppenheimer cut Adobe to “Perform” from…
15 January 2026
······
Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

New York, Jan 15, 2026, 12:24 EST — Regular session Accenture plc shares (ACN) were up about 0.1% at $288.87 on Thursday, holding most of Wednesday’s 4.2% jump. The stock closed the prior session at $288.54. (MarketWatch) The move matters because investors are trying to pin down whether corporate tech budgets are finally thawing, after a year of stop-start spending…
15 January 2026
·····
Home Depot stock nudges higher after Morgan Stanley lifts target as housing signals loom

Home Depot stock nudges higher after Morgan Stanley lifts target as housing signals loom

New York, Jan 15, 2026, 12:21 EST — Regular session underway. Shares of Home Depot (HD) ticked up 0.5% to $377.75 midday Thursday after Morgan Stanley boosted its price target for the home-improvement giant. The firm raised its 12-month target to $412 from $395, maintaining an “Overweight” rating, indicating it expects HD to outperform its peers. Meanwhile, Lowe’s shares crept…
15 January 2026
·····
AbbVie stock slides 2% as obesity push takes center stage at JPM conference

AbbVie stock slides 2% as obesity push takes center stage at JPM conference

New York, January 15, 2026, 12:11 (EST) — Regular session AbbVie shares dropped 2.1% to $217.13 Thursday following the company’s expanded plans for obesity treatments announced at the J.P. Morgan Healthcare Conference. This matters since AbbVie is hunting for its next major growth driver, as its aging blockbuster Humira grapples with increased competition from biosimilars. Investors have shown they’re eager…
15 January 2026
···
Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

New York, January 15, 2026, 12:06 (EST) — Regular session Intuitive Surgical shares dropped once more on Thursday, continuing a selloff sparked by the company’s weaker growth forecast for procedures involving its da Vinci surgical robot. The stock slipped roughly 1% to $541.08 in midday trading, following a 2.7% drop on Wednesday. The procedure forecast is crucial because every da…
15 January 2026
·····
Robinhood stock slides as Senate delays crypto bill after Coinbase CEO balks

Robinhood stock slides as Senate delays crypto bill after Coinbase CEO balks

New York, January 15, 2026, 11:55 EST — Regular session Robinhood Markets shares dropped 3.5% to $115.50 in late-morning trading Thursday, hitting an intraday low of $115.30 earlier in the session. Pressure mounted after the U.S. Senate Banking Committee delayed a scheduled debate on draft legislation aimed at overhauling crypto regulations. Coinbase CEO Brian Armstrong criticized the bill’s current draft,…
15 January 2026
····
UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

New York, January 15, 2026, 12:01 EST — Regular session UnitedHealth Group Incorporated shares rebounded from an early dip, climbing roughly 0.7% to $337.27 by late morning Thursday. The stock had fallen to an intraday low of $328.14 before bouncing back. The rebound came after UnitedHealthcare announced it is trialing quicker payment schedules for rural hospitals— a modest shift, but…
15 January 2026
···
Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

NEW YORK, Jan 15, 2026, 12:16 EST — Trading in the regular session. Boeing (BA) shares climbed 1.6% to $246.40 by midday Thursday following a price target boost from Bernstein. Analyst Douglas S. Harned maintained a Buy rating and raised the target to $298 from $277, according to MarketScreener data. (MarketScreener) The stock hinges on a straightforward issue: whether Boeing…
15 January 2026
······
Why P&G stock is down today as Procter & Gamble flags a $100 Potemkin mini-tender offer

Why P&G stock is down today as Procter & Gamble flags a $100 Potemkin mini-tender offer

New York, Jan 15, 2026, 11:56 ET — Regular session. Procter & Gamble shares dropped about 1.1% to $144.77 in late morning trade Thursday after the consumer goods giant urged investors to spurn an unsolicited “mini-tender” offer from Potemkin Limited. Potemkin proposed buying up to 50,000 shares at $100 each — roughly 31% below the $145.52 closing price on Dec.…
15 January 2026
····
1 … 236 237 238 239 240 … 903

Stock Market Today

  • Novartis (SWX:NOVN) Seen Undervalued Despite Strong Multi-Year Gains
    January 31, 2026, 11:19 AM EST. Novartis shares trade around $114.62 after a 0.9% pullback in the past week and a 1-year return of 24.2%, lagging peers. The pharmaceutical giant boasts 70.3% returns over three years and 80% over five years. Our Discounted Cash Flow (DCF) model, projecting future cash flows until 2030, values Novartis stock at $254.07 per share, suggesting a 54.9% undervaluation versus the current price. With free cash flow projected to rise from $18.2 billion to $21.2 billion by 2030, the company's valuation looks attractive. The price-to-earnings (P/E) ratio complements this view, linking share price to earnings growth and risk. Novartis scores 5 out of 6 on undervaluation metrics, supporting the case for potential entry or hold for investors.
Go toTop